The Rise of eClinical Trials in Health Care

The Rise of eClinical Trials in Health Care

By Pharma Tech Outlook | Tuesday, August 14, 2018

The global e-Clinical solutions market is consisting of various segments that include clinical data management systems (CDMS), electronic data capture (EDC), clinical trial management systems (CTMS), electronic clinical outcome assessment, and safety solutions. eClinical trial solutions denote electronic applications which are implemented in clinical research and most popularly used in the biopharmaceutical industry. e-Clinical is also used to mention technology applications leveraged in ePRO, IVR systems, and EDC. Furthermore, eClinical applications also have web-based applications that bear in collecting the data live from clinical trials for quick and effective enforcement and are also server-based applications.

The ultimate goal behind eClinical technologies is to understand its impacting factors like high costs for drug development, increasing competition, and harsh regulatory environment. There is also approving grants to conduct clinical trials and increasing research and development costs by pharma-biotech companies with higher IT budgets for advancement in drugs. Therefore, pharmaceutical companies are faced with pain points to organize clinical trials resulting in eClinical trial getting integrated. eClinical trial solutions help to minimize human errors, and with the fast urbanization of clinical trials as well as numerous advantages with its implementation, there is advantageous market growth.

eClinical trial solution market is divided into on-demand, cloud-based or SaaS, and on-premise, based on the method of delivery. The trial phase solution is also having different categories of pharmaceutical and biopharmaceutical companies, contract research companies, and medical device manufacturers along with health care and academic research centers.

eClinical trial solutions are spread across various continents like North America, Europe, Asia-pacific, Africa, and the middle east. There is also an escalation in government funding to make use of clinical support and less inflexible norms when compared with developed countries will certainly prove to be a boost to the market.

Weekly Brief

Read Also